DoW Breast Cancer, Clinical Research Extension Award

The Department of Defense’s Breast Cancer Research Program (BCRP) FY26 Clinical Research Extension Award funds a single research effort that extends data collection, follow‑up, and analysis of existing breast‑cancer clinical studies. The award targets projects that address at least one of the program’s overarching challenges, require inclusion of two breast‑cancer consumer advocates, and may be led by a single PI or a partnering‑PI team. Funding is capped at $7 M for a single‑PI award or $8.4 M for a partnering‑PI award, with a maximum four‑year performance period. • Funding: up to $8.4 M total (≈$7 M for single PI, $8.4 M for partnering PI). • Eligibility: U.S. Department of War (DoD) extramural or intramural entities; any nonprofit, for‑profit, domestic or foreign organization. • Key requirement: research team must include ≥2 breast‑cancer consumer advocates. • Submission timeline: Pre‑application (LOI) due 4 Nov 2026; full application due 18 Nov 2026 (11:59 p.m. ET). • Award date: projected 30 Sep 2027; performance start same date, up to 4 years. • Review: Peer review Jan 2027, programmatic review Mar 2027. • Reporting: annual technical progress reports, final report, data‑sharing plan, inclusion reporting. • Contact: eBRAP Help Desk (301‑682‑5507, [email protected]).